Zhiwei Yang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Zhiwei Yang has a total of 180 co-authors. Here are the top co-authors by number of shared publications:
Xing Liu
Institute of Laboratory Animal Science, Chinese Academy of Medical Sciences (CAMS) & Peking Union Medical College (PUMC), National Center of Technology Innovation for Animal Model, NHC Key Laboratory of Human Disease Comparative Medicine, National Human Diseases Animal Model Resource Center, Beijing, 100021, China
21 shared publicationsXiaoliang Jiang
NHC Key Laboratory of Human Disease Comparative Medicine, Institute of Laboratory Animal Sciences (CAMS & PUMC) National Center of Technology Innovation for Animal Model, National Human Diseases Animal Model Resource Center, Beijing Engineering Research Center for Experimental Animal Models of Human Critical Diseases Beijing P.R. China
15 shared publicationsXianxian Wu
Institute of Laboratory Animal Science, Chinese Academy of Medical Sciences (CAMS) & Comparative Medicine Centre, Peking Union Medical College (PUMC), Beijing 100021, China
11 shared publicationsXue Liu
Institute of Laboratory Animal Sciences (CAMS & PUMC) National Center of Technology Innovation for Animal Model National Human Diseases Animal Model Resource Center NHC Key Laboratory of Human Disease Comparative Medicine Beijing Engineering Research Center for Experimental Animal Models of Human Critical Diseases 100021 Beijing China
7 shared publicationsPedro A. Jose
Department of Pharmacology and Physiology (P.A.J.), The George Washington University School of Medicine and Health Sciences, Washington, DC
6 shared publicationsYuhan Li
Institute of Laboratory Animal Science, Chinese Academy of Medical Sciences (CAMS) & Comparative Medicine Centre, Peking Union Medical College (PUMC), Beijing 100021, China
5 shared publications
Latest Publications
- Open Access
- 22 October 2026
- Published by MDPI AG in Journal of Cardiovascular Development and Disease
- Vol. 13 (11) , 531
Sex Disparities in Recorded Heart Failure-Attributed Mortality Among Adults Aged 20–49 Years: A 25-Country Comparison with Broader Mortality Categories
Whether the relative male excess in recorded heart failure (HF)-attributed mortality among adults aged 20–49 years is greater than that for broader mortality categories is unclear. We analysed World Health Organization underlying cause death data for adults aged 20–49 years in 25 countries with complete data for 2001–2019. Stacked count models compared male-to-female mortality rate ratios (MRRs) for HF-attributed, other circulatory, and non-HF all-cause mortality; secondary models estimated temporal changes. Among 200,707 HF-attributed deaths, the median ratio of MRRs was 0.895 for HF-attributed versus other circulatory mortality and 1.128 versus non-HF all-cause mortality. Confidence intervals were entirely above 1 in 4 and 6 of 25 countries, respectively, and entirely below 1 in 5 and 1. Results were similar when the contrast was allowed to vary over time and when the United States, Canada, and Mexico were added, but the comparison with non-HF all-cause mortality depended on the age range. As secondary findings, mortality declined in both sexes in 10 countries, and a male disadvantage was present in 18 countries in both 2001 and 2019. Across these 25 countries, the relative male excess in recorded HF-attributed mortality was not consistently greater than that for broader mortality categories.
- 22 October 2026
- Published by MDPI AG in Journal of Cardiovascular Development and Disease
- Vol. 13 (11) , 531
Open AccessSex Disparities in Recorded Heart Failure-Attributed Mortality Among Adults Aged 20–49 Years: A 25-Country Comparison with Broader Mortality Categories
Whether the relative male excess in recorded heart failure (HF)-attributed mortality among adults aged 20–49 years is greater than that for broader mortality categories is unclear. We analysed World Health Organization underlying cause death data for adults aged 20–49 years in 25 countries with complete data for 2001–2019. Stacked count models compared male-to-female mortality rate ratios (MRRs) for HF-attributed, other circulatory, and non-HF all-cause mortality; secondary models estimated temporal changes. Among 200,707 HF-attributed deaths, the median ratio of MRRs was 0.895 for HF-attributed versus other circulatory mortality and 1.128 versus non-HF all-cause mortality. Confidence intervals were entirely above 1 in 4 and 6 of 25 countries, respectively, and entirely below 1 in 5 and 1. Results were similar when the contrast was allowed to vary over time and when the United States, Canada, and Mexico were added, but the comparison with non-HF all-cause mortality depended on the age range. As secondary findings, mortality declined in both sexes in 10 countries, and a male disadvantage was present in 18 countries in both 2001 and 2019. Across these 25 countries, the relative male excess in recorded HF-attributed mortality was not consistently greater than that for broader mortality categories.
- Open Access
- 31 August 2026
- Published by MDPI AG in Biomolecules
- Vol. 16 (9) , 1262
Kcna3 Deficiency Promotes Renin-Associated Hypertension Through Ca2+-Dependent AKT–PKA–CREB Signaling
Hypertension is an important risk factor for cardiovascular and renal diseases, yet the mechanisms linking ion channel dysfunction to hypertension remain poorly understood. The voltage-gated potassium channel Kv1.3 (encoded by Kcna3) regulates membrane potential, but its role in the pathogenesis of hypertension remains unclear. In this study, we employed Kcna3 knockout (KO) mice, transcriptomic profiling, and pharmacological inhibition to investigate the role of Kv1.3. Kcna3-deficient mice showed increased blood pressure and renal fibrosis. Transcriptomic profiling showed activation of the renin–angiotensin–aldosterone system (RAAS), with increased renin expression in both Kcna3-deficient mice and Kv1.3 inhibitor-treated cells. Mechanistically, loss of Kv1.3 increased intracellular Ca2+ accumulation, activating the phosphoinositide 3-kinase (PI3K)-AKT and protein kinase A (PKA) pathways, leading to cAMP response element binding protein (CREB) phosphorylation and renin upregulation. Pharmacological inhibition of Ca2+ signaling or PKA reduced CREB phosphorylation and renin expression, confirming a causal signaling cascade. Thus, Kv1.3 links membrane excitability to RAAS activation via a Ca2+-dependent AKT–PKA–CREB signaling axis and represents a potential therapeutic target for hypertension and associated renal injury.
- 31 August 2026
- Published by MDPI AG in Biomolecules
- Vol. 16 (9) , 1262
Open AccessKcna3 Deficiency Promotes Renin-Associated Hypertension Through Ca2+-Dependent AKT–PKA–CREB Signaling
Hypertension is an important risk factor for cardiovascular and renal diseases, yet the mechanisms linking ion channel dysfunction to hypertension remain poorly understood. The voltage-gated potassium channel Kv1.3 (encoded by Kcna3) regulates membrane potential, but its role in the pathogenesis of hypertension remains unclear. In this study, we employed Kcna3 knockout (KO) mice, transcriptomic profiling, and pharmacological inhibition to investigate the role of Kv1.3. Kcna3-deficient mice showed increased blood pressure and renal fibrosis. Transcriptomic profiling showed activation of the renin–angiotensin–aldosterone system (RAAS), with increased renin expression in both Kcna3-deficient mice and Kv1.3 inhibitor-treated cells. Mechanistically, loss of Kv1.3 increased intracellular Ca2+ accumulation, activating the phosphoinositide 3-kinase (PI3K)-AKT and protein kinase A (PKA) pathways, leading to cAMP response element binding protein (CREB) phosphorylation and renin upregulation. Pharmacological inhibition of Ca2+ signaling or PKA reduced CREB phosphorylation and renin expression, confirming a causal signaling cascade. Thus, Kv1.3 links membrane excitability to RAAS activation via a Ca2+-dependent AKT–PKA–CREB signaling axis and represents a potential therapeutic target for hypertension and associated renal injury.
- 24 June 2026
- Published by Elsevier in Atherosclerosis
- Vol. 419, 120835
G6PD inhibition prevents abdominal aortic aneurysm formation in mice induced by Ang II plus high salt
- 24 June 2026
- Published by Elsevier in Atherosclerosis
- Vol. 419, 120835
G6PD inhibition prevents abdominal aortic aneurysm formation in mice induced by Ang II plus high salt
- Open Access
- 9 June 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (12) , 5235
Knockout of α-Synuclein Is Associated with Depression-like Behaviors by Altered Excitability of Medial Prefrontal Cortex Neurons in Mice
To investigate the neural circuit mechanisms linking the physiological loss of α-synuclein (α-syn) function to depressive-like states, we explored whether constitutive α-syn depletion disrupts the excitation and inhibition balance within the medial prefrontal cortex. We integrated comprehensive behavioral paradigms, whole-cell patch-clamp electrophysiology, and targeted chemogenetics within an α-syn knockout mouse model. Behavioral profiling revealed that α-syn deficiency was accompanied by basal psychomotor hyperactivity and profound stress-coping deficits. Cellular electrophysiology in the medial prefrontal cortex demonstrated a significantly enhanced intrinsic excitability across both GABAergic and glutamatergic populations. Furthermore, targeted chemogenetic suppression of GAD67-positive interneurons partially alleviated the depressive-like phenotype without confounding baseline locomotion. In summary, the physiological depletion of endogenous α-syn is associated with altered stress-coping behaviors and increased mPFC neuronal excitability. Chemogenetic suppression of mPFC GAD67-positive interneurons partially reduces immobility in SYN-KO mice, implicating prefrontal inhibitory circuit dysregulation in these behavioral alterations. These findings underscore the importance of α-syn homeostasis in modulating cortical microcircuits and provide novel insights into the early non-motor manifestations of synucleinopathies.
- 9 June 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (12) , 5235
Open AccessKnockout of α-Synuclein Is Associated with Depression-like Behaviors by Altered Excitability of Medial Prefrontal Cortex Neurons in Mice
To investigate the neural circuit mechanisms linking the physiological loss of α-synuclein (α-syn) function to depressive-like states, we explored whether constitutive α-syn depletion disrupts the excitation and inhibition balance within the medial prefrontal cortex. We integrated comprehensive behavioral paradigms, whole-cell patch-clamp electrophysiology, and targeted chemogenetics within an α-syn knockout mouse model. Behavioral profiling revealed that α-syn deficiency was accompanied by basal psychomotor hyperactivity and profound stress-coping deficits. Cellular electrophysiology in the medial prefrontal cortex demonstrated a significantly enhanced intrinsic excitability across both GABAergic and glutamatergic populations. Furthermore, targeted chemogenetic suppression of GAD67-positive interneurons partially alleviated the depressive-like phenotype without confounding baseline locomotion. In summary, the physiological depletion of endogenous α-syn is associated with altered stress-coping behaviors and increased mPFC neuronal excitability. Chemogenetic suppression of mPFC GAD67-positive interneurons partially reduces immobility in SYN-KO mice, implicating prefrontal inhibitory circuit dysregulation in these behavioral alterations. These findings underscore the importance of α-syn homeostasis in modulating cortical microcircuits and provide novel insights into the early non-motor manifestations of synucleinopathies.
- Open Access
- 1 October 2025
- Published by Wiley in Animal Models and Experimental Medicine
- Vol. 8 (10) , 1775-1784
Animal models of hypertension and concurrent organs injury
Although hypertension is a frequently seen chronic condition across the world, its exact cause remains unclear. Animal models are beneficial for clarifying the pathogenic mechanism of hypertension and examining new treatments. An optimal animal model for studies on hypertension must well mimic human‐like hemodynamics and pathophysiological structural modification, showing human disease features and complications timely or even ahead of time. A review of the most frequently used hypertensive animal models available, including small and large animals, induced and genetic models, would provide an insight into the appropriate targets to be addressed in the development of different hypertensive animal models. Another focus of the review are the processes of target‐organs injury caused by high blood pressure, which mainly influences human health.
- 1 October 2025
- Published by Wiley in Animal Models and Experimental Medicine
- Vol. 8 (10) , 1775-1784
Open AccessAnimal models of hypertension and concurrent organs injury
Although hypertension is a frequently seen chronic condition across the world, its exact cause remains unclear. Animal models are beneficial for clarifying the pathogenic mechanism of hypertension and examining new treatments. An optimal animal model for studies on hypertension must well mimic human‐like hemodynamics and pathophysiological structural modification, showing human disease features and complications timely or even ahead of time. A review of the most frequently used hypertensive animal models available, including small and large animals, induced and genetic models, would provide an insight into the appropriate targets to be addressed in the development of different hypertensive animal models. Another focus of the review are the processes of target‐organs injury caused by high blood pressure, which mainly influences human health.
- Open Access
- 30 August 2025
- Published by Ivyspring International Publisher in Theranostics
- Vol. 15 (18) , 9486-9507
Single-cell RNA sequencing reveals endothelial cell heterogeneity and Sox18-mediated EndMT in abdominal aortic aneurysm
Rationale: Abdominal aortic aneurysm (AAA) is a life-threatening cardiovascular disease lacking clinical predictors and effective pharmacologic therapies. The cellular heterogeneity and molecular changes of different cell types during AAA have been revealed in human and mouse aortas by single-cell RNA sequencing (scRNA-seq) technology. However, the heterogeneity and plasticity of endothelial cells (ECs) in AAA remain poorly characterized.
- 30 August 2025
- Published by Ivyspring International Publisher in Theranostics
- Vol. 15 (18) , 9486-9507
Open AccessSingle-cell RNA sequencing reveals endothelial cell heterogeneity and Sox18-mediated EndMT in abdominal aortic aneurysm
Rationale: Abdominal aortic aneurysm (AAA) is a life-threatening cardiovascular disease lacking clinical predictors and effective pharmacologic therapies. The cellular heterogeneity and molecular changes of different cell types during AAA have been revealed in human and mouse aortas by single-cell RNA sequencing (scRNA-seq) technology. However, the heterogeneity and plasticity of endothelial cells (ECs) in AAA remain poorly characterized.
- Top Cited PapersOpen Access
The Pathophysiological Role of Vascular Smooth Muscle Cells in Abdominal Aortic Aneurysm
Abdominal aortic aneurysm (AAA) is the most common aortic disease occurring below the renal arteries, caused by multiple etiologies. Currently, no effective drug treatment exists, and the specific pathogenesis remains unclear. Due to its insidious onset and diagnostic challenges, AAA often culminates in aortic rupture, which has a high mortality rate. During AAA development, vascular smooth muscle cells (VSMCs) undergo significant pathological alterations, including contractile dysfunction, phenotypic modulation, cellular degradation, and heightened inflammatory and oxidative stress responses. In particular, emerging evidence implicates vascular smooth muscle cell (VSMC) metabolic dysregulation and mitochondrial dysfunction as key contributors to AAA progression. In this review, we systematically summarize the current understanding of VSMC biology, including their developmental origins, structural characteristics, and functional roles in aortic wall homeostasis, along with the regulatory networks governing the VSMC phenotype and functional maintenance. This review highlights the urgent need for further investigation into the aortic wall VSMC pathophysiology to identify novel therapeutic targets for AAA. These insights may pave the way for innovative treatment strategies in aortic disease management.
Top Cited PapersOpen AccessThe Pathophysiological Role of Vascular Smooth Muscle Cells in Abdominal Aortic Aneurysm
Abdominal aortic aneurysm (AAA) is the most common aortic disease occurring below the renal arteries, caused by multiple etiologies. Currently, no effective drug treatment exists, and the specific pathogenesis remains unclear. Due to its insidious onset and diagnostic challenges, AAA often culminates in aortic rupture, which has a high mortality rate. During AAA development, vascular smooth muscle cells (VSMCs) undergo significant pathological alterations, including contractile dysfunction, phenotypic modulation, cellular degradation, and heightened inflammatory and oxidative stress responses. In particular, emerging evidence implicates vascular smooth muscle cell (VSMC) metabolic dysregulation and mitochondrial dysfunction as key contributors to AAA progression. In this review, we systematically summarize the current understanding of VSMC biology, including their developmental origins, structural characteristics, and functional roles in aortic wall homeostasis, along with the regulatory networks governing the VSMC phenotype and functional maintenance. This review highlights the urgent need for further investigation into the aortic wall VSMC pathophysiology to identify novel therapeutic targets for AAA. These insights may pave the way for innovative treatment strategies in aortic disease management.
- 20 May 2025
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
- Vol. 1871 (6) , 167917
A novel transgenic miniature pig model of human PSGL-1 reveals critical roles in thrombosis, inflammation, and immune perturbation
- 20 May 2025
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
- Vol. 1871 (6) , 167917
A novel transgenic miniature pig model of human PSGL-1 reveals critical roles in thrombosis, inflammation, and immune perturbation
- Open Access
- 24 March 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-17
Foxk1 and Foxk2 promote cardiomyocyte proliferation and heart regeneration
Promoting endogenous cardiomyocyte proliferation is a promising strategy for cardiac repair. Identifying key factors that regulate cardiomyocyte proliferation can advance the development of novel therapies for heart regeneration. Here, we identify Foxk1 and Foxk2 as key regulators of cardiomyocyte proliferation, whose expression declines during postnatal heart development. Cardiomyocyte-specific knockout of Foxk1 or Foxk2 impairs neonatal heart regeneration after myocardial infarction (MI) injury. AAV9-mediated Foxk1 or Foxk2 overexpression extends the postnatal cardiomyocyte proliferative window and enhances cardiac repair in adult mice after MI. Mechanistically, Foxk1 and Foxk2 drive cardiomyocyte cell cycle progression by directly activating CCNB1 and CDK1 expression, forming the CCNB1/CDK1 complex that facilitates G2/M transition. Moreover, Foxk1 and Foxk2 promote cardiomyocyte proliferation by upregulating HIF1α expression, which enhances glycolysis and the pentose phosphate pathway (PPP), which further favors cardiomyocyte proliferation. These findings establish Foxk1 and Foxk2 as promising therapeutic targets for cardiac injury.
- 24 March 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-17
Open AccessFoxk1 and Foxk2 promote cardiomyocyte proliferation and heart regeneration
Promoting endogenous cardiomyocyte proliferation is a promising strategy for cardiac repair. Identifying key factors that regulate cardiomyocyte proliferation can advance the development of novel therapies for heart regeneration. Here, we identify Foxk1 and Foxk2 as key regulators of cardiomyocyte proliferation, whose expression declines during postnatal heart development. Cardiomyocyte-specific knockout of Foxk1 or Foxk2 impairs neonatal heart regeneration after myocardial infarction (MI) injury. AAV9-mediated Foxk1 or Foxk2 overexpression extends the postnatal cardiomyocyte proliferative window and enhances cardiac repair in adult mice after MI. Mechanistically, Foxk1 and Foxk2 drive cardiomyocyte cell cycle progression by directly activating CCNB1 and CDK1 expression, forming the CCNB1/CDK1 complex that facilitates G2/M transition. Moreover, Foxk1 and Foxk2 promote cardiomyocyte proliferation by upregulating HIF1α expression, which enhances glycolysis and the pentose phosphate pathway (PPP), which further favors cardiomyocyte proliferation. These findings establish Foxk1 and Foxk2 as promising therapeutic targets for cardiac injury.